OpenAlex
PricingAboutJobs
Log inGet started
Work

Long-term safety of ketamine and esketamine in treatment of depression

HTML

Year: 2022
Type: review
Source: Expert Opinion on Drug Safety
DOI: 10.1080/14740338.2022.2066651
Authors: Sina Nikayin, Eva Murphy, John H. Krystal, Samuel T. Wilkinson
Institution: Yale University
Language: English

Topic: Treatment of Major Depression
Subfield: Pharmacology (medical)
Field: Medicine
Domain: Health Sciences
Keywords: ketamine, esketamine, treatment-resistant depression, long-term safety, dissociation, urinary tract symptoms, cognitive impairment, rapid-acting antidepressants, adverse effects
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W4223474449
FWCI: 2.797
Cites: 85
Cited by: 139
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security